Covered recipient · General Payments record
JOSEPH MORAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,675.98
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $356.45 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $177.35 | 5 |
| ABBVIE INC. | $45.86 | 2 |
| Mylan Specialty L.P. | $36.00 | 2 |
| PFIZER INC. | $32.87 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.16 | 1 |
| Acerta Pharma LLC | $18.32 | 1 |
| GENZYME CORPORATION | $17.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.89 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105063784 | CMS |
| ABBVIE INC. | $20.97 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105063786 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.32 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104599072 | CMS |
| GENZYME CORPORATION | $17.89 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139574613 | CMS |
| GlaxoSmithKline, LLC. | $19.99 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116213182 | CMS |
| GlaxoSmithKline, LLC. | $125.00 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116594022 | CMS |
| GlaxoSmithKline, LLC. | $11.46 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115972763 | CMS |
| GlaxoSmithKline, LLC. | $3.51 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116275485 | CMS |
| GlaxoSmithKline, LLC. | $17.39 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116624789 | CMS |
| Mylan Specialty L.P. | $22.12 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147309554 | CMS |
| Mylan Specialty L.P. | $13.88 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147295135 | CMS |
| PFIZER INC. | $19.56 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131615838 | CMS |
| PFIZER INC. | $13.31 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131615842 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.16 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137638178 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.